Search our Insights Archive

Syndicated report Stephen Potts Syndicated report Stephen Potts

Tumor Agnostic testing – Awareness of biomarkers, Market landscape and Approaches

Tumor agnostic indications present specific challenges that must be addressed to achieve a successful launch and ensure wide access for all patients. To prepare for these complex product and indications launches, it is paramount for commercial teams to gain insights on tumor agnostic testing behaviors, including awareness, adoption, drivers and barriers.

Read More